Thyroid parameters during therapy with zotepine in delusional depression. Preliminary results

Neuropsychobiology

Volumn 37, Issue 2, 1998, Pages 88-90

  König, Frank ^a   Hauger, Barbara ^a   Barg, Thomas ^a   Wolfersdorf, Manfred ^b  

^a UNIVERSITY OF ULM   (Germany)

^b Bezirkskrankenhaus F Psychiatrie   (Germany)

Author keywords

Delusional depression; Neuroleptic zotepine; Thyroid parameters

Indexed keywords

LIOTHYRONINE; NEUROLEPTIC AGENT; PROTIRELIN; THYROID HORMONE; ZOTEPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DELUSION; DEPRESSION; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL;

ADULT; ANTIPSYCHOTIC AGENTS; DELUSIONS; DEPRESSIVE DISORDER; DIBENZOTHIEPINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES;

EID: 0031939272     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026489     Document Type: Article

References (23)

1. American Psychiatric Association (APA: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, 1994.
2. World Health Organization: International Classification of Diseases. Tenth Revision (ICD-10). Geneva, WHO, 1992,
3. Schatzberg AF, Rothschild AJ: Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733-745.
4. Baumgartner A, Campos-Carros A: Schilddrü-senhormone und depressive Erkrankungen. Kritische Übersicht und Perspektiven. Nervenarzt 1993;64:1-20.
5. Joffe RT, Levitt AJ: The thyroid and schizophrenia; in Joffe RT. Levitt AJ (eds): The Thyroid Axis and Psychiatric Illness. Washington, Am Psychiatric Press, pp 317-325.
6. Beasley CM, Magnusson M, Garver DL: TSH response to TRH and haloperidol response latency in psychoses. Biol Psychiatr 1988;24: 423-431.
7. Baumgartner A, Graf KJ, Kurten I: The hypothalamic-pituitary-thyroid axis in psychiatric patients and healthy subjects, II. Psychiatr Res 1988;24:283-305.
8. Martinos A, Rinieris P, Souvatzoglou A: Effects of six weeks neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. Neuropsychobiology 1980;16:72-77.
9. Rinieris P, Christodoulow GN, Souvatzoglou A, Kontras DA, Stefanis C: Free-thyroxin index in schizophrenic patients before and after neuroleptic treatment. Neuropsychobiology 1980;6:29-33.
10. Kirkegaard C, Bjorum N, Cohn D: Thyrotropin-releasing hormone (TRH) stimulation test in manic-depressive illness. Arch Gen Psychiatry 1978;35:1017-1021.
11. Magliozzi JR, Gold A, Laubly JN: Effect of oral administration of haloperidol on plasma thyrotropin concentrations in man. Psychoneuroen-docrinology 1989;14:125-130.
12. Naber D, Steinbeck H, Greil W: Effects of short and long neuroleptic treatment on thyroid function. Prog Neuropsychopharmacol 1980;4:199-206.
13. Colln R, Jequier JC, Leboeuf G: Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 1977;44: 981-984.
14. Van Bardeleben U, Benkert U, Holsboer F: Clinical and neuroendocrine effects of zotepine - a new neuroleptic drug. Pharmacopsychiatry 1987;20(suppl):28-34.
15. Wolfersdorf M, König F, Straub R: Pharmacotherapy of delusional depression: Experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol. Neuropsychobiology 1994;29:189-193.
16. Wolfersdorf M, König F, Barg T, Straub R: Monotherapie der wahnhaften Depression mit Zotepin; in Möller HJ. Müller-Spahn F, Kurtz G (eds): Biologische Psychiatrie. Wien, Springer, 1996, pp 240-243.
17. Wolfersdorf M, König F, Barg T: Monotherapie der wahnhaften Depression mit dem sogenannten atypischen Neuroleptikum Zotepin - Ergebnisse einer Anwendungsbeobachtung über 28 Tage. Nervenheilkunde, in press.
18. Passath A, Leb G, Goebel R: Oraler TRH-Test mit 40 mg TRH: Stimulationsbreite und Vergleich mit 200 μg TRH intravenös. Acta Med Austria 1980;3:80-87.
19. Hoenle R: Der orale TRH-TSH-Test bei 'Low-Responders' und 'Non-Responders' im i.v. TRH-TSH-Test. Diagn Intersivther 1980;5: 21-23.
20. Müller WE: Das Rezeptorbindungsprofil von Zotepine im Vergleich zu anderen Antipsychotika. Psychopharmakotherapie 1995;2(suppl 3):4-5.
21. Vanelle JM, Poirier MF, Benkelfat C, Galinowski A, Sechter D, Suzini de Luca H, Lôo M: Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients. Acta Psychiatr Scand 1990; 81:156-161.
22. Shelton RC, Winn S, Ekhatore N, Loosen PT: The effects of antidepressants on the thyroid axis in depression. Biol Psychiatry 1993;33: 120-126.
23. Lambert TJ, Davidson R, Mc Lellan GM: Euthyroid hyperthyroxinaemia in acute psychiatric admissions. Aust NZ J Psychiatry 1987;21: 608-614.